Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R D Hadden

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Current Opinion in Neurology|December 11, 1999
Treatment of immune-mediated inflammatory neuropathiesR D Hadden, R A Hughes
Hospital Medicine (London, England : 1998)|November 3, 1998
Guillain-Barré syndrome: recent advancesR D Hadden, R A Hughes
Symposium Series (Society for Applied Microbiology)|June 26, 2001
Guillain--Barré syndrome and Campylobacter jejuni infectionR D Hadden, N A Gregson
Journal of the Royal College of Physicians of London|July 14, 1999
Autoimmune inflammatory neuropathyR D Hadden, M P Lunn, R A Hughes
Journal of Neuroimmunology|March 1, 2000
Pathogenesis of Guillain-Barré syndromeR A Hughes, R D Hadden, N A Gregson, et al.
Brain : a Journal of Neurology|May 13, 1998
The Italian Guillain-Barré Study Group. The prognosis and main prognostic indicators of Guillain-Barré syndrome: a multicentre prospective study of 297 patientsR A Hughes, R D Hadden, J H Rees, et al.
Neurology|July 17, 1999
Randomized trial of interferon beta-1a in chronic inflammatory demyelinating polyradiculoneuropathyR D Hadden, B Sharrack, S Bensa, et al.
European Journal of Neurology|September 6, 2000
Randomized controlled trial of brain-derived neurotrophic factor in Guillain-Barré syndrome: a pilot studyS Bensa, R D Hadden, A Hahn, et al.
Journal of Neuroimmunology|October 5, 2001
Guillain-Barré syndrome serum and anti-Campylobacter antibody do not exacerbate experimental autoimmune neuritisR D Hadden, N A Gregson, R Gold, et al.
Neurology|June 20, 1998
Wegener's granulomatosis presenting with bulbar palsy and bilateral jugular vein compressionR D Hadden, D Meikle, A Coulthard, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Current Opinion in Neurology|December 11, 1999
Treatment of immune-mediated inflammatory neuropathiesR D Hadden, R A Hughes
Hospital Medicine (London, England : 1998)|November 3, 1998
Guillain-Barré syndrome: recent advancesR D Hadden, R A Hughes
Symposium Series (Society for Applied Microbiology)|June 26, 2001
Guillain--Barré syndrome and Campylobacter jejuni infectionR D Hadden, N A Gregson
Journal of the Royal College of Physicians of London|July 14, 1999
Autoimmune inflammatory neuropathyR D Hadden, M P Lunn, R A Hughes
Journal of Neuroimmunology|March 1, 2000
Pathogenesis of Guillain-Barré syndromeR A Hughes, R D Hadden, N A Gregson, et al.
Brain : a Journal of Neurology|May 13, 1998
The Italian Guillain-Barré Study Group. The prognosis and main prognostic indicators of Guillain-Barré syndrome: a multicentre prospective study of 297 patientsR A Hughes, R D Hadden, J H Rees, et al.
Neurology|July 17, 1999
Randomized trial of interferon beta-1a in chronic inflammatory demyelinating polyradiculoneuropathyR D Hadden, B Sharrack, S Bensa, et al.
European Journal of Neurology|September 6, 2000
Randomized controlled trial of brain-derived neurotrophic factor in Guillain-Barré syndrome: a pilot studyS Bensa, R D Hadden, A Hahn, et al.
Journal of Neuroimmunology|October 5, 2001
Guillain-Barré syndrome serum and anti-Campylobacter antibody do not exacerbate experimental autoimmune neuritisR D Hadden, N A Gregson, R Gold, et al.
Neurology|June 20, 1998
Wegener's granulomatosis presenting with bulbar palsy and bilateral jugular vein compressionR D Hadden, D Meikle, A Coulthard, et al.
Pageof 2